SLC22A1 and prostate carcinoma: For example, the AR peak ‘chr6:160561950‐160562800′, with a RECWAS p value of 6.20e‐06 and a CWAS p value of 1.73e‐02, has been previously identified in the work of Huang et al.,[53] as a prostate cancer‐associated ARBS near the SLC22A1 gene.